| Pharmaceutical Information |
| Drug Name |
Mecamylamine |
| Drug ID |
BADD_D01356 |
| Description |
A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool. |
| Indications and Usage |
For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension |
| Marketing Status |
Not Available |
| ATC Code |
C02BB01 |
| DrugBank ID |
DB00657
|
| KEGG ID |
C07511
|
| MeSH ID |
D008464
|
| PubChem ID |
4032
|
| TTD Drug ID |
D0V8HA
|
| NDC Product Code |
Not Available |
| Synonyms |
Mecamylamine |
|
| Chemical Information |
| Molecular Formula |
C11H21N |
| CAS Registry Number |
60-40-2 |
| SMILES |
CC1(C2CCC(C2)C1(C)NC)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
